Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2003
12/31/2003WO2003051334A3 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support
12/31/2003WO2003047549A3 Post-coated liposome/lipoplex for targeted drug/gene delivery and lipid linked to a delivery, targeting or stabilising moiety
12/31/2003WO2003024383A3 Methods and apparatus for improved administration of analgesics
12/31/2003WO2002098388A3 Effervescent formulations of non-steroidal anti-inflammatory drugs
12/31/2003WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization
12/31/2003WO2002048110A3 Composition for regulating animal growth, method of manufacture and use thereof
12/31/2003WO2002047615A3 Oral compositions and use thereof
12/31/2003WO2002043750A8 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
12/31/2003WO2002042325A3 Cyp1b1 nucleic acids and methods of use
12/31/2003WO2002040055A3 Solutions and films of glycated chitosan
12/31/2003CN2595367Y Plaster back adhesive film
12/31/2003CN1464791A Compositions for protein delivery via the pulmonary route
12/31/2003CN1464788A Pharmaceutical compositions for headache, migraine, nausea and emesis
12/31/2003CN1464774A Improved hard sugar coating method
12/31/2003CN1463746A Micro-emulsified pre-concentration oral solution containing Ciclosporin A
12/31/2003CN1463733A Plaster for treating hypertension
12/31/2003CN1463727A A TCM compound recipe notoginseng capsule and method for preparing the same
12/31/2003CN1463722A A method for treating cancer and ache
12/31/2003CN1463720A Ginseng-leech capsule for treating coronary disease and stenocardia and process for preparing same
12/31/2003CN1463719A Process for preparing medicinal smoke treating fragrance using bath method
12/31/2003CN1463700A Silymarin nano granular preparation and process for preparing the same
12/31/2003CN1463697A Fluctin slow release tablet
12/31/2003CN1463696A Biological active control release microsphere and method for preparing same
12/31/2003CN1132635C Immediately disintegrable medicinal compositions
12/31/2003CN1132633C Pharmaceutical compositions containing gellants in form of alkyl amides of di- and tri-carboxylic acids
12/31/2003CN1132632C 缓释药物组合物 Release pharmaceutical composition
12/31/2003CN1132625C 包胶在透明质酸微粒中的缓释药物组合物 Hyaluronic acid particles encapsulated in a sustained-release pharmaceutical compositions
12/31/2003CN1132620C Aseptic 'Shenmai' powder for injection and its preparing process
12/31/2003CN1132615C Health-care product with function of regulating blood sugar and its preparation method
12/31/2003CN1132614C Medicine for treating hemicrania and its preparing process
12/31/2003CN1132613C Anti-impotence kidney-tonifying capsule
12/31/2003CN1132609C Oral liquid for removing endogenous heat
12/31/2003CN1132607C Yunnan pine nut extract and preparation process and use thereof
12/31/2003CN1132603C Compound Wuduqing capsule of blister beetle
12/31/2003CN1132598C 'Yishentongbi' pill for treating hyperosteogeny and its preparing process
12/31/2003CN1132595C Eye disease preventing oral liquid and its preparation
12/31/2003CN1132592C Chinese medicine gel powder
12/31/2003CN1132591C Chewing tablets of pilose antler, deerhorn and deer bone and preparing process thereof
12/31/2003CN1132589C Process for preparing plaster to promote circulation of blood and vital energy
12/31/2003CN1132582C High-content famciclovir tablets
12/31/2003CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions
12/31/2003CN1132576C Method for fixing Chinese-medicinal bone-setting paper
12/31/2003CN1132575C Targeting controlled-release microcapsule capable of inducing environment information quickly
12/31/2003CN1132574C Eye medicine prepn. for computer eyesight syndrome and xerophthalmia
12/31/2003CN1132573C Long-lasting composition for rectal administration
12/31/2003CN1132566C Process for encapsulation of caplets in capsule and solid dasage forms obtainable by such process
12/31/2003CA2712349A1 Popping oral administration form
12/31/2003CA2492047A1 Short duration depot formulations
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2491152A1 Oral pharmaceutical forms of liquid drugs having improved bioavailability
12/31/2003CA2490704A1 Process for producing block copolymer/drug composite
12/31/2003CA2490516A1 Honey-based skin care preparation
12/31/2003CA2490365A1 Quick dissolve compositions and tablets based thereon
12/31/2003CA2490341A1 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
12/31/2003CA2490325A1 Transdermal aerosol compositions
12/31/2003CA2490232A1 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2490057A1 Metastable pharmaceutical compositions
12/31/2003CA2489997A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
12/31/2003CA2489987A1 Fluorosiloxane matrix controlled diffusion drug delivery system
12/31/2003CA2489984A1 Pharmaceutical compositions with improved dissolution
12/31/2003CA2489949A1 Breath freshening and oral cleansing product with cinnamaldehyde
12/31/2003CA2489806A1 Liposomes containing biologically active compounds
12/31/2003CA2489702A1 Novel anticholesterol compositions and method for using same
12/31/2003CA2489554A1 Actuation indicator for a dispensing device
12/31/2003CA2489528A1 Nasal compositions comprising a mucopolysaccharide and propylene glycol
12/31/2003CA2489347A1 Transdermal drug delivery system
12/31/2003CA2489308A1 Use of taurine for the treatment of alopecia
12/31/2003CA2488942A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof
12/31/2003CA2487716A1 Pharmaceutical composition for the intranasal application containing selected cgrp antagonists derived from amino acids and process for preparing them
12/30/2003US6670485 Vision disorders
12/30/2003US6670452 Non-naturally occurring lipoprotein particle
12/30/2003US6670407 Contacting a mixture of substrates or their precursors with a supercritical fluid under supercritical conditions and reduced viscosity and physical blending to plasticise and swell polymer and distribute biofunctional material
12/30/2003US6670399 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited
12/30/2003US6670395 Phenoxyacetic acid and/or a lower alkyl ester thereof
12/30/2003US6670393 Carbamate-based cationic lipids
12/30/2003US6670390 Polyphenols and procyanidins; increasing nitric oxide synthesis
12/30/2003US6670384 Methods of administering epothilone analogs for the treatment of cancer
12/30/2003US6670349 Asthma
12/30/2003US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group
12/30/2003US6670118 Method for treating papillomavirus infections
12/30/2003US6670038 Method of depositing particles with an electrostatic chuck
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669964 Composition for solubilizing salicylic acid
12/30/2003US6669963 Stable particle in liquid formulations
12/30/2003US6669962 Starch microcapsules for delivery of active agents
12/30/2003US6669961 Microparticles
12/30/2003US6669960 Contacting drug-containing solution with compressed antisolvent fluid to precipitate drug-containing particles, feed solution including drug in cosolvent system including first and second organic solvents, separating particles
12/30/2003US6669958 Gel delivery vehicles for anticellular proliferative agents
12/30/2003US6669957 Solid pills/pharmaceutical comprising paracetamol or tramadol dispersed in diluents and vinyl acetate-vinylpyrrolidinone copolymer as excipients, to form tablets having good texture and taste
12/30/2003US6669956 Tablets incorporating isoflavone plant extracts and methods of manufacturing them
12/30/2003US6669955 Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
12/30/2003US6669954 Coated, apertured container permeable to water that is only semi-permeable to a pharmaceutical agent in the container
12/30/2003US6669953 Transdermal patches comprising pressure sensitive adhesives for delivery fo drugs such as isosorbide mononitrate, indomethacin or ketoprofen; sustained release
12/30/2003US6669952 Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669950 Biocompatible implants for localized delivery of pharmaceutically active agent to the posterior segment of the eye
12/30/2003US6669948 Cefuroxime, cefpodoxime, amoxicillin and dioxacillin; first, second, and third dosage forms with different release profiles, reaching a Cmax in < twelve hours
12/30/2003US6669947 Stratified and cryogenically stored vaccines, process for their preparation
12/30/2003US6669929 Dentifrice containing functional film flakes
1 ... 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 ... 2991